Fidelity Disruptive Medicine ETF

23.64

+0.05290.22%

Volume:2.90K

Turnover:68.53K

Market Cap:50.22M

PE:- -

High:23.73

Open:23.73

Low:23.45

Close:23.59

Loading ...

Overview Company News Filings

Concept

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Agilon Health Adjusts To Recovery Phase, Analyst Is Cautious On Near-Term Fundamentals

Benzinga

·

19 Mar

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/FMED"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"FMED","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FMED\",,,,,undefined,":{"symbol":"FMED","market":"US","secType":"STK","nameCN":"Fidelity Disruptive Medicine ETF","latestPrice":23.6439,"timestamp":1745870400000,"preClose":23.591,"halted":0,"volume":2898,"delay":0,"floatShares":2123806,"shares":2123806,"eps":0,"marketStatus":"Pre-Mkt","change":0.0529,"latestTime":"04-29 05:06:39 EDT","open":23.73,"high":23.73,"low":23.45,"amount":68529.9087,"amplitude":0.011869,"askPrice":37.59,"askSize":100,"bidPrice":9.46,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745933400000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":23.6439,"sharesOutstanding":2123806,"nav":23.648855,"aum":50225580.14213,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":23.61,"preClose":23.6439,"latestTime":"16:05 EDT","volume":3,"amount":70.9317,"timestamp":1745870713886},"volumeRatio":0.9278944820679829},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FMED\",,,,,undefined,":{"symbol":"FMED","floatShares":2123806,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.9278944820679829,"shares":2123806,"dividePrice":0.113,"high":23.73,"amplitude":0.011869,"preClose":23.591,"low":23.45,"week52Low":20.69,"pbRate":"--","week52High":26.79,"institutionHeld":0,"latestPrice":23.6439,"committee":0.333333,"eps":0,"divideRate":0.004779,"volume":2898,"delay":0,"ttmEps":0,"open":23.73,"prevYearClose":24.6605,"prevWeekClose":23.591,"prevMonthClose":23.61,"prevQuarterClose":23.61,"fiveDayClose":22.1424,"twentyDayClose":23.8869,"sixtyDayClose":26.6065},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/FMED\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FMED\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2520327379","title":"Agilon Health Adjusts To Recovery Phase, Analyst Is Cautious On Near-Term Fundamentals","url":"https://stock-news.laohu8.com/highlight/detail?id=2520327379","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520327379?lang=en_us&edition=fundamental","pubTime":"2025-03-19 02:32","pubTimestamp":1742322730,"startTime":"0","endTime":"0","summary":"J.P. Morgan analyst Lisa C. Gill, with a Neutral rating, updated estimates for Agilon Health, Inc.  following fourth-quarter results posted last month.Last month, the company reported a fourth-quarter 2024 adjusted EPS of $, missing the consensus estimate of $. However, sales for the quarter totaled $1.52 billion, which is in line with expectations.The analyst’s revised estimates reflect an updated outlook on AGL’s recovery timeline based on management’s recent commentary.With 2025 expected to be a year of transition, the company aims to address specific challenges while navigating another year of high trends, positioning itself to achieve its targets for 2026/2027, adds the analyst.The analyst estimates revenue of $1.502 billion  and adjusted EBITDA of $16 million  in the first quarter of FY25.For FY25, Gill revised the revenue estimate to $5.926 billion  from $6.453 billion earlier while adjusted EBITDA loss estimate remains unchanged at $77 million .For FY26, the analyst updated the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/agilon-health-adjusts-recovery-phase-183210123.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["FMED","BK4196","AGL","BK4539"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FMED\",params:#limit:5,,,undefined,":[{"date":"2024-12-20","symbol":"FMED","amount":0.112,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-20","defaultRemindTime":1734705000000,"name":"Fidelity Disruptive Medicine ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-20","currency":"USD","dateTimestamp":1734670800000,"payDate":"2024-12-24"},{"date":"2024-06-21","symbol":"FMED","amount":0.001,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-21","defaultRemindTime":1718976600000,"name":"Fidelity Disruptive Medicine ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-25","payableDate":"2024-06-21","currency":"USD","dateTimestamp":1718942400000,"payDate":"2024-06-25"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FMED\",market:\"US\",,,undefined,":[{"executeDate":"2024-06-21","recordDate":"2024-06-21","paymentDate":"2024-06-25","value":0.001,"currency":"USD"},{"executeDate":"2024-12-20","recordDate":"2024-12-20","paymentDate":"2024-12-24","value":0.112,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FMED\",market:\"US\",delay:false,,,undefined,":{}}}